Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peribulbar Anesthesia for Pain Management During PRP in Proliferative Diabetic Retinopathy
NCT07640256Phase 4Completed
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jul 2023
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine and lidocaine in pain (2 arms), sponsored by Asociación para Evitar la Ceguera en México. Primary endpoint: Pain perception at 15 months. Started Jul 2023; status: completed.
02
Drugs
bupivacainelidocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07640256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640256.